Responses
Clinical/translational cancer immunotherapy
Original research
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Compose a Response to This Article
Other responses
No responses have been published for this article.
